Inspira Financial Inc. : Penny Stock Fun and Profits ?

Inspira Financial Inc. Releases Quarterly Results; Update on Loan Book and Operations

Marketwired

WALNUT CREEK, CALIFORNIA–(Marketwired – Oct 29, 2015) – Inspira Financial Inc. (TSX VENTURE:LND) (“Inspira”) today announced results from the quarter ending August 31st, 2015.

After securing more than $25 million in public equity financing, as well as debt financing privately and through the issuance of public debentures, Inspira launched full operations in February 2015 into the fragmented marketplace of small companies in the large and growing market for alternative financial services offered to healthcare providers and their patients across the United States.

Inspira’s initial product offering addresses the needs of a $1 trillion market of small healthcare providers across the U.S. Inspira currently offers several types of financing options for small businesses in the industry, including:

  • 3-year revolving lines of credit and loans ranging from $250,000 to $5 million with total interest and fees ranging from 12%-18%;
  • 90-day to 1-year revolving lines of credit and loans ranging from $5 million to $15 million with interest rates ranging from 8%-14%; and
  • 90-day to 1-year introductory lines of credit for up to $250,000 often used to initiate a relationship with a customer before moving to a larger and longer term line of credit.

Financial and Business Highlights:

  • End of September 2015 loan book in excess $50 million, as compared to $35 million at the end of May 2015.
  • Generated annualized (interest and fee) revenue of approximately $4 million in August 2015.
  • Generated operational profit of approximately $465,000, not including one-time origination fees for the quarter ending August 31, 2015.
  • Created a proprietary online tool for credit line applications, due diligence and loan management.
  • Established several origination channels, ranging in cost (in one-time fees) from 0.25% to 1.5% of the initial loan.
  • Responded to over 200 inquiries and applications for loans and lines of credit since full launch in February 2015.
  • Management reasserts its goal of a $500 million loan book with no further equity financings, assuming fully- diluted capitalization and 80% leverage.

“Since we finalized our financing we have been able to ramp our loan book quickly with a very small, but focused, team,” said David Costine, CEO of Inspira. “In just seven months we’ve built a loan book of over $50 million and generated an operational profit of $465,000 just this quarter,” continued Mr. Costine. “Our annuity stream revenue gives me confidence that our quarter-over-quarter growth will remain strong and we continue to invest heavily in origination partners as well as internal staff and are seeing these investments pay off as we increase our growth rate every quarter to achieve our goal of a $500 million loan book.”

“We’re starting to develop good momentum in several areas in this market,” continued Mr. Costine. “Our primary focus continues to be lines of credit in the million dollar range with yields as high as 18% and our strategy of offering small, introductory loans to catalyze our loan book as well as larger, short-term loans to generate strong cash flows appear to be working. As we grow, we expect to continue broadening our offerings and have recently ramped up our efforts to identify accretive acquisitions that can move our loan book size to over $100 million.”

Related Quotes

About Inspira Financial and the Fast Growing Market

The healthcare market in the U.S. is a rapidly expanding industry, with spending expected to exceed $4.5 trillion by 2020. Within this industry, over 1 million businesses have annual revenues in the $1 million to $50 million range. The emerging reimbursement trend towards more usage-based procedures, along with the fact that healthcare providers are being forced to increase patient volumes to maintain or grow profit levels, creates a need for increased efficiency and greater front-end investment in technology and larger staff sizes. These factors, as well as the realities that insurance providers are taking longer to pay than before and that patients are now bearing increased financial responsibility for medical bills, contribute to significant financial pressure and net working capital challenges for the average, smaller sized healthcare practice in the U.S.

Overall, traditional banks continue to reduce their risk profiles, term lenders require personal guarantees and first security over all assets, factoring lenders charge 25%+ annual interest and equipment providers have all but eliminated financing programs. The increasingly limited number of options for obtaining revolving lines of credit and loans for smaller healthcare providers creates a supply shortage in the market. This imbalance represents an opportunity for alternative lending companies catering to this demographic to capitalize upon. By targeting the 1 million+ healthcare providers in the U.S., Inspira believes it can generate high returns on government (Medicare/Medicaid) and large healthcare insurance receivables. Inspira plans to acquire debt and increase profitability through cross selling of financial services.

Trading Alert: PHM Moving – Another 52 Week High After Financing

 

Vector cartoon of business man reading newspaper with stock market rising - Stock Illustration: 26398687

 

Out top spec pick moved lower when a $58 million dollar bought deal ( at $1.50 this week) was announced. Investors digested that news and conluded that the money would propel the M&A strategy more than issuing stock to the target companies .The price jumped back from a decline to $1.60

 

We are now up 50 % from our initial buy-in and the NASDAQ listing it wants needs a $2.00 U.S. handle.

PATIENT HOME MONITORING CORP(PHM:TSXV, CA)

1.80CADIncrease0.06(3.45%)Volume: 
Above Average
As of 16 Apr 2015 at 11:22 AM EDT.

 

QUOTE DETAILS

Open 1.79 P/E Ratio (TTM)
Last Bid/Size 1.79 / 2156 EPS (TTM) -0.03
Last Ask/Size 1.80 / 282 Next Earnings
Previous Close 1.74 Beta -0.21
Volume 2,930,211 Last Dividend
Average Volume 4,982,340 Dividend Yield
Day High 1.83 Ex-Dividend Date
Day Low 1.76 Shares Outstanding 231.8M
52 Week High 1.83 # of Floating Shares 210.4501M
52 Week Low 0.2200 Short Interest as % of Float
DRIP Eligible No

 

COMPANY DESCRIPTION

Patient Home Monitoring Corp. is a healthcare company. The Company is engaged in providing in-home monitoring equipment, supplies and services to patients in the United States. The Company’s 100% equity subsidiaries include PHM DME Healthcare, Inc, Stancap Holdings I Limited, Patient Home Monitoring, Inc., PHM Health Management, Inc., Healthcare Logistics Corporation, Hollywood Healthcare Corporation, Resource Medical Group, LLC

 

Trading Alert : PHM at 52 week high on volume Press Release Update

This never gets old – still our top spec pick

 

Patient Home Monitoring (PHM) Announces Another Record of Quarterly Revenue and Profits

LOS ANGELES, CALIFORNIA–(Marketwired – April 9, 2015) –

 

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN

Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable, acquisition-oriented company focused on providing annuity-based healthcare products and services to patients in the home throughout the US, today announced highlights of its Fiscal Year 2015 second quarter revenues and profits in advance of a presentation to capital market participants in Montreal to accept the award for being a 2015 TSX Venture 50 company and the top company in the Technology & Life Sciences category.

 

Financial highlights for the quarter ending March 31, 2015:

 

Revenues:

Total quarterly revenues exceeded $13,000,000; an increase of 28% from the previous quarter and 255% from the quarter a year ago.

March 2015 revenues exceeded $5,000,000, translating to an annualized revenue run rate in excess of $60,000,000.

 

Revenue Growth:

Inorganic quarterly revenue growth was approximately $1,800,000.

  • 2 months of Black Bear Medical (reported unaudited annualized revenues of $8,500,000 or approximately $700,000 monthly).
  • 1 month of West Home Health (reported unaudited annualized revenues of $5,500,000 or $450,000 monthly).

Organic quarterly revenue growth was approximately $1,100,000, an annualized organic revenue growth rate in excess of 40%.

 

Profitability:

  • Adjusted EBITDA(1)exceeded $2,850,000; an increase of 20.3% from the previous quarter and 259% from the same quarter a year ago.
  • Net profit before stock-based compensation(2)exceeded $1,600,000; an increase of 23.5% from the previous quarter.
  • Annualized Adjusted EBITDA run rate in excess of $11,400,000.

 

PHM continues to build its pipeline of qualified acquisition targets:

  • 152 qualified targets in initial contact phase.
  • 16 active targets in initial due diligence.
  • 8 term sheets in negotiation.
  • 2 additional LOI’s pending signature from seller.
  • 4 LOI’s executed – 2 expected to close this quarter.
  • 2 large acquisition targets with revenues in excess $40 million

PHM is rolling-up a large and fragmented market of small, profitable businesses providing healthcare products and services to chronically ill patients. The companies are acquired for their technical and market expertise in certain product and service lines, as well as their patient databases. Once acquired, PHM works to offer these newly acquired services to its entire patient base, thereby increasing revenue per patient and achieving organic post acquisition revenue growth and profits.

 

“This quarter we had both impressive organic revenue growth and additional revenues from acquisitions,” said Michael Dalsin, Chairman of PHM. “While we didn’t have the full impact of both acquisitions this quarter, we were still able to generate better than expected revenue growth. Next quarter, we will get the full impact of these acquisitions, along with additional cross selling revenue as our management team integrates the businesses.”

“In terms of our M&A pipeline, I do expect that we will close our four outstanding LOIs quite soon,” continued Mr. Dalsin. “Since adding to our M&A staff, we have built a very large pipeline which, in my experience, should give us the ability to pick the very best deals. We continue to work with the larger acquisition targets to finalize deal terms and I am cautiously optimistic that we may land a larger deal soon as well. We will continue to focus on our large and growing pipeline of deals to ensure we can achieve our year end run rate revenue goal.”

As in the case of other quarterly financial results, the foregoing figures are unaudited. Full financial results from this quarter will be available on SEDAR expected before their due date of June 1, 2015.

 

About PHM

 

PHM is an acquisition-oriented, fast-growing and profitable company servicing patients with heart disease and other chronic health conditions. PHM is focused on acquiring companies in a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively identifying and evaluating profitable, annuity-based companies to acquire at favorable prices for their patient databases and technical expertise. PHM’s post-acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.

 

 

 

PATIENT HOME MONITORING CORP(PHM:TSXV, CA)

1.62CADIncrease0.05(3.18%)Volume: 
Average
As of 09 Apr 2015 at 11:04 AM EDT.

QUOTE DETAILS

Open 1.60 P/E Ratio (TTM)
Last Bid/Size 1.61 / 1266 EPS (TTM) -0.03
Last Ask/Size 1.62 / 1127 Next Earnings
Previous Close 1.57 Beta -0.26
Volume 1,364,909 Last Dividend
Average Volume 4,486,840 Dividend Yield
Day High 1.62 Ex-Dividend Date
Day Low 1.58 Shares Outstanding 231.8M
52 Week High 1.62 # of Floating Shares 191.2059M
52 Week Low 0.2200 Short Interest as % of Float
DRIP Eligible No
chart
5 day chart

 

PHM – Our Top 2015 Spec Play : Update / Trading Alert

PHM Announces Execution of Letter of Intent (LOI) to Acquire Another Large Regional Business in Tennessee With $20 Million in Revenue and $4 Million in Adjusted EBITDA

 

PATIENT HOME MONITORING CORP(PHM:TSXV, CA)

1.30CADIncrease0.09(7.44%)Volume: 
Above Average
As of 16 Mar 2015 at 10:51 AM EDT.

Management to Hold a Conference Call on Wednesday, March 18th to Review Acquisition Pipeline

chart

Jack A. Bass Managed Accounts average  $1.11

 

LOS ANGELES, CALIFORNIA–(Marketwired – March 16, 2015) –

 

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN.

Patient Home Monitoring (PHM) (TSX VENTURE:PHM), a profitable company with annualized revenues exceeding $55 million focused on rolling-up annuity-based healthcare service companies in the U.S. and Canada, announced it has executed a non-binding Letter of Intent (LOI) to acquire a company in Tennessee with unaudited approximate annualized revenues of $20,000,000 and Adjusted EBITDA of $4,000,000(1).

PHM’s Chairman and executive team will hold a conference call scheduled for 1 pm EST, Wednesday, March 18, 2015.

PHM also provided updated details on the cancellation of the small $2.25 million annual revenue Georgia business LOI.

 

The Tennessee Letter of Intent (LOI)

The Tennessee business is a large, regionally-focused company offering home-based medical equipment and services for patients with chronic pulmonary conditions. The business services over 40,000 active patients. After close, PHM plans to start immediately offering cardiology and mobility services to these patients with an eye toward increasing organic revenues and profits of the business.

According to the LOI, PHM will acquire 100% of the outstanding shares of the business for cash for a total consideration of $14,348,000. PHM has sufficient cash on the balance sheet to complete the acquisition. Closing the acquisition will be subject to final due diligence and a binding purchase agreement.

 

The Georgia LOI Cancelled

PHM was unable to reach an agreement on the final terms of the purchase agreement with the Georgia Company, particularly with respect to issues of indemnification.

 

Summary of Active LOIs

The table below summarizes the current status of PHM and the status of PHM after all LOIs are closed, Further, it summarizes the breakdown of the revenues and Adjusted EBITDA for each acquisition and the cash needed to close the acquisition. PHM plans to use $26,798,000 to close the acquisitions announced. PHM is expected to have over $10,000,000 in cash after all LOIs have closed, with revenues of $96,500,000(2) and Adjusted EBITDA of $19,450,000(2).

 

Annualized Revenue Annualized Adjusted EBITDA Cash Balance
PHM Today $ 55,000,000 $ 10,500,000 $ 37,000,000
PHM Post-LOIs closed $ 96,500,000 $ 19,450,000 $ 10,202,000
Summary of LOIs Cash To Close
Colorado $ 16,500,000 $ 4,000,000 $ 11,000,000
Oklahoma & Texas $ 5,000,000 $ 950,000 $ 1,450,000
Tennessee $ 20,000,000 $ 4,000,000 $ 14,348,000
Totals $ 41,500,000 $ 8,950,000 $ 26,798,000

“The Tennessee deal is another large acquisition for PHM and, when closed, we will likely have reached our 2015 goal of achieving $100 million in annual revenue earlier than planned,” said Michael Dalsin, Chairman of PHM. “Along with the acquisition, we plan to draw down on a line of credit to ensure we have plenty of cash for further acquisitions.

“In the coming quarters, we are poised to complete the several acquisitions announced this year, almost doubling our revenue, significantly increasing EBITDA, and perhaps most importantly, adding over 90,000 patients to our database,” continued Mr. Dalsin. “After we close all executed LOIs, I expect we will have a cash balance of over $10 million and we will be generating Adjusted EBITDA of close to $20 million per year(1). I expect these numbers will increase once we see the results of cross selling such a large patient database.”

“Considering the small size of the business in Georgia and the potential of significant trailing liabilities,’ concluded Mr. Dalsin. “We have decided that the risk-reward ratio was not in our favor.”

 

Conference Call March 18, 2015 to Review Acquisition Pipeline

PHM will host an interactive Q&A conference call at 1p.m. EST on Wednesday, March 18, 2015.

Participants from PHM will be Michael Dalsin (Chairman), Roger Greene (Vice Chairman), David Hayes (CEO) and Edward Brann (M&A Banker).

The details of the call are:

 

Wednesday, March 18, 2015 at 1p.m. EST

US & Canada Toll Free:

Dial In: (855) 886-8711

Meeting ID Number: 548 01 39

Financial professionals are invited to call in and ask questions. To pre-register as a qualified caller, please e-mail dwilson@myphm.com by 5 p.m. EST Tuesday, March 17th, 2015.

 

About PHM

The explosive growth in the number of elderly patients in the US healthcare market is creating pressure to provide more efficient delivery systems. Healthcare providers, such as hospitals, physicians and pharmacies, are seeking partners that can offer a range of products and services that improve outcomes, reduce hospital readmissions, and help control costs. PHM fills this need by delivering a growing number of specialized products and services to achieve these goals. PHM is a positive cash flow and profitable company that serves patients with heart disease and other chronic health conditions, this operation is a platform for acquisitions and organic growth. PHM is focused on a highly fragmented and developing market of small privately-held companies servicing chronically ill patients with multiple disease states caused mainly by age and obesity. Because of the new and highly fragmented nature of the market, PHM is actively working to identify and evaluate profitable, annuity-based companies to acquire their patient databases and technical expertise at favorable prices. PHM’s post acquisition organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient. The expected result is growing EPS with each acquisition and growing revenue and profits from the cross selling efforts.

 

Our Spec Pick March 2015 : Make Money with Old Sick People

Sick Bed cartoons, Sick Bed cartoon, funny, Sick Bed picture, Sick Bed pictures, Sick Bed image, Sick Bed images, Sick Bed illustration, Sick Bed illustrations

Patient Home Monitoring Corp. (PHM.V)

KEY: Highly focused management, expanding merger and acquisition strategy

Growth story unfolding – still little known

Please check out the website and latest news releases

TSXV 

1.22 Up 0.01(0.83%) 9:53AM EDT
Prev Close: 1.21
Open: 1.21
Bid: 1.22
Ask: 1.23
1y Target Est: N/A
Beta: N/A
Next Earnings Date: N/A
Day’s Range: 1.211.22
52wk Range: 0.22 – 1.27
Volume: 221,662
Avg Vol (3m): 3,312,280
Market Cap: 239.21M
P/E (ttm): N/A
EPS (ttm): -0.03
Div & Yield: N/A (N/A)
Profile Get Profile for:
Patient Home Monitoring Corp.
14724 Ventura Boulevard
Suite 1250
Sherman Oaks, CA 91403
United States – Map
Website: http://www.phmhometesting.com

Details
Index Membership: N/A
Sector: Healthcare
Industry: Medical Appliances & Equipment
Full Time Employees: N/A
Business Summary

Patient Home Monitoring Corp. provides and rents in-home monitoring equipment, supplies, and services for patients in the United States. It offers diabetic testing supplies and other medications, power mobility equipment, home durable medical equipment, and respiratory services. The company is headquartered in Sherman Oaks, California.

 

Asanko Gold Inc. Spec BUY

AKG : TSX : C$2.50
AKG : NYSE MKT
SPECULATIVE BUY 
Target: C$3.25

COMPANY DESCRIPTION:
The combination of AKG and PMI created a significant gold
development company with 2P reserves of 4.8 Moz with a
permitted, financed (US$231M in cash, Q2/14) mine plan on half
the reserve (Obotan project) with the permit in hand with a permit
pending on the other half (Esaase project). All the assets are
within the Ghana, one of the premier jurisdictions in the entire
African continent.
All amounts in C$ unless otherwise noted.

Metals and Mining — Exploration and Development
GOLD ROYALTY ON PHASE 1 REDUCED FROM 7% TO 5% NSR
Investment recommendation
The company announced an agreement to buyback a 2% NSR reducing
the overall NSR from 7% to 5% for Phase 1 (Obotan) of the Asanko Gold
Mine in Ghana, West Africa. We view the acquisition of the NSR as a
strong positive and highly accretive given that the Phase 1 project is
breaking ground and close to production (H1/16E). We raised our target
(+C$0.10) accordingly to C$3.25, a 30% premium to current price levels,
and maintained our SPECULATIVE BUY recommendation. We anticipate
more construction updates leading to a resource update for Phase 1
followed by an updated mine plan (Q4/14E

Investment highlights
 Our revised target price is based on an increase in our NPV8% (+4%
to US$733 M) of the combined Obotan (Phase 1) and Esaase (Phase
2) gold projects, now known as the Asanko Gold Mine, related to the
reduction of the NSR at Phase 1 (Obotan) from 7% to 5%. On an
NPV8% basis, we valued the 2% NSR on Phase 1 at C$25-30 M (LT
US$1422) The drop in our NSR assumption from 7% to 5% for Phase 1 is
related to the recently announced purchase of the 2% Goknet
(privately held company) NSR for 1 M shares of AKG and cash (we
estimate US$1 M as the details were not disclosed). In addition, AKG
will transfer the rights to two exploration projects, Kubi and Diaso,
which the company deems as non-material.
 In November 2012, Asante Gold Corp. (ASE : TSX-V
offered to purchase half (1%) of the 2% NSR on the Obotan project
from Goknet for C$22.5 M via shares (45 Msh, C$0.50), which
would now be worth about C$4 M (for 1% NSR). The sale was never
completed

Trading Alert : NEWL Longs Taste Revenge

Pounded day after day the stock slipped below a dollar.

today the start was as bad and the decline was into the 70 cent range.

In the past hour buying is so great the Level Two quotes cannot keep up – likely shorts trying to lock in profits of the last week.

NEWLEAD HOLDINGS LTD(NEWL:NASDAQ, US)

1.10USDIncrease0.155(16.40%)Volume: 
Above Average
As of 03 Jun 2014 at 1:29 PM EDT.

QUOTE DETAILS

Open 0.8800 P/E Ratio (TTM)
Last Bid/Size 1.09 / 25 EPS (TTM) -56,034.36
Last Ask/Size 1.10 / 104 Next Earnings
Previous Close 0.9450 Beta 2.14
Volume 28,730,744 Last Dividend
Average Volume 15,875,201 Dividend Yield 0.00%
Day High 1.11 Ex-Dividend Date
Day Low 0.7300 Shares Outstanding 10.1M
52 Week High 8,235.00 # of Floating Shares 3.06757M
52 Week Low 0.3788 Short Interest as % of Float 0.50%

 

NEWL up 200 % – More Fun with Pennies

a bit of fun with the spec stock  trading account

NEW YORK (TheStreet) — NewLead Holdings (NEWL_) stock is soaring Monday after the shipper announced its eco-type handysize vessel, Newlead Albion, had been delivered to the NewLead fleet. The vessel has capacity of 32,318 dwt.

The company said the Newlead Albion is expected to generate $2 million EBITDA per year, assuming $1.73 million yearly OPEX.  

Our Exclusive Richardson / Bass  Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months

Jack a. Bass Managed Accounts

email info@jackbassteam.com

or

Call Jack direct at 604-858-3202 Pacific time

Monday – Friday 9:00- 5:00

Albion, one of two eco-type vessels which NewLead agreed to acquire in March, was purchased for $18.5 million. At current prices, the market value of the vessel is around $20.25 million each. The second vessel is scheduled for delivery in July.

“We are pleased to announce the delivery of the Newlead Albion, the first vessel to be added to our fleet after our successful restructuring. To receive delivery, we secured financing through a leading shipping and financial institution, demonstrating third party belief in the transformation of NewLead,” chairman and CEO Michael Zolotas said in a statement.

Zolotas, added, “We are modernizing our fleet with fuel efficient vessels. The fleet age is being optimized, and employment lifetime is substantially longer. NewLead expects to have three new modern Handysize vessels added to its fleet by the end of August 2014.”

By midmorning, shares had added 66.8% to $1.05.

NEWLEAD HOLDINGS LTD(NEWL:NASDAQ, US)

1.10USDIncrease0.4704(74.71%)Volume: 
Above Average
As of 19 May 2014 at 10:19 AM EDT

QUOTE DETAILS

Open 0.8000 P/E Ratio (TTM)
Last Bid/Size 1.10 / 5 EPS (TTM) -56,034.36
Last Ask/Size 1.11 / 46 Next Earnings
Previous Close 0.6296 Beta 2.30
Volume 5,462,658 Last Dividend
Average Volume 3,363,711 Dividend Yield 0.00%
Day High 1.19 Ex-Dividend Date
Day Low 0.7500 Shares Outstanding 10.1M
52 Week High 8,235.00 # of Floating Shares 10.02893M
52 Week Low 0.3788 Short Interest as % of Float 0.53%
chart
 CLOSE

NEWLEAD HOLDINGS LTD(NEWL:NASDAQ, US)

BuySell
1.95USDIncrease1.32(209.72%)Volume: 
Above Average
As of market close 19 May 2014.

QUOTE DETAILS

Open 0.8000 P/E Ratio (TTM)
Last Bid/Size 1.90 / 11 EPS (TTM) -56,034.36
Last Ask/Size 1.96 / 15 Next Earnings
Previous Close 0.6296 Beta 2.30
Volume 32,273,804 Last Dividend
Average Volume 3,363,711 Dividend Yield 0.00%
Day High 2.97 Ex-Dividend Date
Day Low 0.7500 Shares Outstanding 10.1M
52 Week High 8,235.00 # of Floating Shares 10.02893M
52 Week Low 0.3788 Short Interest as % of Float 0.53%

Niko Resources Continues To Disappoint

As I repeat in my book The Apprentice Millionaire Portfolio ( available from Amazon.com ) it is often as important to know what stocks to avoid as to buy. Jack A. Bass Managed Accounts hold no shares in NKO.

NIKO RESOURCES LTD(NKO:TSX, CA)

BuySell
4.33CADDecrease0.41(-8.65%)Volume:
Above Average
As of 04 Sep 2013 at 1:26 PM EDT.

 

QUOTE DETAILS
Open 4.71 P/E Ratio (TTM)
Last Bid/Size 4.33 / 28 EPS (TTM) -3.24
Last Ask/Size 4.34 / 44 Next Earnings
Previous Close 4.74 Beta 1.22
Volume 597,373 Last Dividend
Average Volume 633,753 Dividend Yield
Day High 4.71 Ex-Dividend Date
Day Low 4.30 Shares Outstanding 70.2M
52 Week High 18.50 # of Floating Shares 65.61045M
52 Week Low 4.30 Short Interest as % of Float

 

Here is a July article from this blog – prior to Niko having exited Indonesia and the potential opportunity there.

NIKO Resources, Motley Fool and The AMP Hedge Fund

Mutual Funds for Dummies ... U.S. Funds at War...Mutual Funds for Dummies … U.S. Funds at War — Too simple? (Monday, June 4, 2012) …item 3.. Music to Help Study and Work – 26:39 minutes … (Photo credit: marsmet545)

The AMP Hedge Fund tracks a good number of stocks for consideration – few as frustrating as NIKO . Great potential – but they used to say that about me.

My advice to myself is that it is better to be a little late into a position than to be early.

Thus we track NIKO ( NKO on Toronto) but haven’t taken a position. Years ago the stock was $ 114 and headed to $ 200 on the basis of massive potential . Natural gas discoveries in India , Indonesia andTrinidad. Swinging for the fences is not an investment strategy it is gambling.

Yet NIKO has the production in India – getting paid a below market rates to satisfy the election bets of the

corrupt .

Track and watch and wait.

Similarly – watch the potential natural gas conversion for trucking offered by Clean Energy and Westport Innovations. Westport has been ” touted ” by Motley Fool . Touted to gain paid followers – the bet has not paid off for the followers.